米国成人のアルゼンチンの暴露と2型糖尿病の罹患率
Ana Navas-Acien1, Ellen K Silbergeld, Roberto Pastor-Barriuso
1Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Room W7033B, Baltimore, MD 21205, USA. anavas@jhsph.edu
JAMA
|August 21, 2008
まとめ
尿中のアルセンの総量は,米国の成人の2型糖尿病のより高い罹患率と関連していました. これは,無機アルゼンチンの曝露が糖尿病に寄与する可能性があることを示唆し,さらなる調査を正当化しています.
科学分野:
- 環境衛生 環境衛生 環境衛生
- エンドクリノロジー エンドクリノロジー
- 毒理学 毒理学 毒理学
背景:
- 高度な慢性無機ヒ素暴露は糖尿病と関連しています.
- 糖尿病のリスクに対する低度から中度までの無機ヒ素暴露の影響は不明である.
- 魚介類からのアルセノベタインは,無毒であると考えられています.
研究 の 目的:
- 尿中のヒ素濃度と2型糖尿病の罹患率との関連を調べる.
- 研究は,米国の成人の代表的なサンプルに焦点を当てた.
主な方法:
- 2003~2004年のNHANES.より20歳以上の788人の成人を対象とした横断研究.
- 尿中のヒ素濃度 (総量,ディメチルアルシネート,アルセンベタイン) を測定した.
- 2型糖尿病の罹患率は,ヒ素摂取量全体で評価されました.
主要な成果:
- 2型糖尿病の参加者は,尿中のアルゼン濃度が合計で26%高かった.
- 2型糖尿病の確率は,アルゼンとディメチルルシネートの総濃度が高くなるにつれて著しく増加しました.
- 2型糖尿病と2型糖尿病のない参加者の間でアルセノベタインのレベルは違わなかった.
結論:
- 尿中のアルセンは,低暴露レベルでも,2型糖尿病の罹患率の増加と関連しています.
- 発見は,飲料水中の無機ヒ素が糖尿病の流行に寄与する可能性があるという仮説を裏付けている.
- 原因関係を確認するためにさらなる見通し研究が必要である.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Hyperosmolar Hyperglycemic State
20
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
20


